Get in Touch

Partnering

Kenjockety’s BASE^TM Platform creates a new family of antibodies and generates an extensive pipeline of bispecific antibody (BsAb) therapeutics. We are looking for industry partners who share in our mission to discover and develop effective treatments to address the unmet needs of patients with drug resistance cancers. We are interested in establishing multiple partnerships and research collaboration that combine expertise and resources to achieve our objectives of advancing multiple programs in our pipeline and improving the lives of patients with cancer.

Please contact us if you are interested in learning more about our partnering strategy.